The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction
Keywords: Farnesoid X receptor; FXR agonist; PX20606; Portal hypertension; Fibrosis; Cirrhosis; Bacterial translocation; Intestinal permeability; Rat; Mouse;